NYSE:MDHealthcare
Pediatrix Medical Group (MD) Reaffirms Outlook Following Stable Payor Mix, Is The Strength Already Priced In?
Pediatrix Medical Group (MD) drew fresh attention after confirming that its second quarter payor mix remained stable and reaffirming its full year 2026 Adjusted EBITDA outlook of $280 million to $300 million, distinguishing it from sector peers.
See our latest analysis for Pediatrix Medical Group.
That update on Pediatrix Medical Group comes after a sharp 1 day share price return of 7.34% to $25.88, building on a 30 day share price return of 6.20% and a one year total shareholder return of...